1,151
Views
9
CrossRef citations to date
0
Altmetric
Author's View

RIPK3—a predictive marker for personalized immunotherapy?

Article: e1075695 | Received 17 Jul 2015, Accepted 17 Jul 2015, Published online: 08 Apr 2016

References

  • Glavan TM, Pavelic J. The exploitation of Toll-like receptor 3 signaling in cancer therapy. Current Pharm Des 2014; 20:6555-64; PMID:25341932; http://dx.doi.org/10.2174/1381612820666140826153347
  • Smola-Hess S, Pfister HJ. Immune Evasion In Genital Papillomavirus Infection And Cervical Cancer: Role Of Cytokines And Chemokines. In: Campo S, ed. Papillomavirus Research: From Natural History To Vaccines and Beyond; Caister Academic Press, 2006
  • Altenburg A, Baldus SE, Smola H, Pfister H, Hess S. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma. J Immunol 1999; 162:4140-7; PMID:10201939
  • Guess JC, McCance DJ. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 2005; 79:14852-62; PMID:16282485; http://dx.doi.org/10.1128/JVI.79.23.14852-14862.2005
  • Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, Melief CJ, van der Burg SH, Boer JM. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PloS One 2011; 6:e17848; PMID:21423754
  • Hess S, Smola H, Sandaradura De Silva U, Hadaschik D, Kube D, Baldus SE, Flucke U, Pfister H. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol 2000; 165:1939-48; PMID:10925276; http://dx.doi.org/10.4049/jimmunol.165.4.1939
  • Pahne-Zeppenfeld J, Schroer N, Walch-Ruckheim B, Oldak M, Gorter A, Hegde S, Smola S. Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells. Int J Cancer 2014; 134:2061-73; PMID:24136650; http://dx.doi.org/10.1002/ijc.28549
  • Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S. Molecular Pathobiology of Human Cervical High-Grade Lesions: Paracrine STAT3 Activation in Tumor-Instructed Myeloid Cells Drives Local MMP-9 Expression. Cancer Res 2011; 71:87-97; PMID:21199798; http://dx.doi.org/10.1158/0008-5472.CAN-10-2193
  • Schmidt SV, Seibert S, Walch-Ruckheim B, Vicinus B, Kamionka EM, Pahne-Zeppenfeld J, Solomayer EF, Kim YJ, Bohle RM, Smola S. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1alpha release, and efficient paracrine dendritic cell activation. Oncotarget 2015; 6:8635-47; PMID:25888634
  • Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148:213-27; PMID:22265413; http://dx.doi.org/10.1016/j.cell.2011.11.031